© 2010 Elsevier Ltd. All rights reserved.We characterized 353 isolates responsible for pediatric invasive pneumococcal infections (IPD) in Portugal between 2006 and 2008. Serotypes included in the seven-valent conjugate vaccine (PCV7) accounted for 17% of IPD. Serotypes 1, 7F and 19A were the most frequent causes of IPD and the later consolidated as the most frequent serotype among erythromycin and penicillin non-susceptible isolates. Serotype 1 was associated with older children and empyemas, while serotype 19A was associated with IPD in younger (<2 years) children. The higher valency vaccines PCV10 and PCV13 have a potentially superior coverage, 55% and 83% respectively, but non-vaccine serotypes are emerging as important causes of ...
Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide....
Although serogroup 6 was among the first to be recognized among Streptococcus pneumoniae, several ne...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
© 2010 Elsevier Ltd. All rights reserved.We characterized 353 isolates responsible for pediatric inv...
<div><p>In Portugal, pneumococcal conjugate vaccines have been administered to children outside of t...
We evaluated the impact of continued 13-valent pneumococcal conjugate vaccine (PCV13) use in the pr...
We evaluated the impact of continued 13-valent pneumococcal conjugate vaccine (PCV13) use in the pri...
The 10-valent pneumococcal conjugate vaccine (PCV10) became available in Portugal in mid-2009 and th...
Eurosurveillance. © 2007 - 2021. All rights reservedThe 10-valent pneumococcal conjugate vaccine (PC...
Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide....
Among the over 90 serotypes of Streptococcus pneumoniae described, serotypes 1, 5, and 7F account fo...
Since 2010 the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent vaccine (PCV7)...
AbstractThe seven-valent pneumococcal conjugate vaccine (PCV7) has been available in Portugal since ...
ABSTRACTThe pneumococcal seven-valent conjugate vaccine (PCV7) has been administered in Portugal sin...
AbstractSerotypes causing invasive pneumococcal disease (IPD) in children aged <2 years in Catalonia...
Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide....
Although serogroup 6 was among the first to be recognized among Streptococcus pneumoniae, several ne...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
© 2010 Elsevier Ltd. All rights reserved.We characterized 353 isolates responsible for pediatric inv...
<div><p>In Portugal, pneumococcal conjugate vaccines have been administered to children outside of t...
We evaluated the impact of continued 13-valent pneumococcal conjugate vaccine (PCV13) use in the pr...
We evaluated the impact of continued 13-valent pneumococcal conjugate vaccine (PCV13) use in the pri...
The 10-valent pneumococcal conjugate vaccine (PCV10) became available in Portugal in mid-2009 and th...
Eurosurveillance. © 2007 - 2021. All rights reservedThe 10-valent pneumococcal conjugate vaccine (PC...
Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide....
Among the over 90 serotypes of Streptococcus pneumoniae described, serotypes 1, 5, and 7F account fo...
Since 2010 the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent vaccine (PCV7)...
AbstractThe seven-valent pneumococcal conjugate vaccine (PCV7) has been available in Portugal since ...
ABSTRACTThe pneumococcal seven-valent conjugate vaccine (PCV7) has been administered in Portugal sin...
AbstractSerotypes causing invasive pneumococcal disease (IPD) in children aged <2 years in Catalonia...
Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide....
Although serogroup 6 was among the first to be recognized among Streptococcus pneumoniae, several ne...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...